未登录
分享
收藏
分享
收藏Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
Lucas, K. J.; Lopez, P.; Lawitz, E.; Sheikh, A.; Aizenberg, D.; Hsia, S.; Bee, G. G. Boon; Vierling, J.; Frias, J.; White, J.; Eguchi, Y.; Lazas, D.; Neff, G.; Yoneda, M.; Augustin, S.; Kim, W.; Loeffler, Y.; Schaefer, F.; Lamle, S.; Martic, M.; Brass, C.; Sanyal, A.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Sulpiride augmentation in people with schizophrenia partially responsive to clozapine - A double-blind, placebo-controlled study
Shiloh, R; Zemishlany, Z; Aizenberg, D; Radwan, M; Schwartz, B; Dorfman-Etrog, P; Modai, I; Khaikin, M; Weizman, A
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Differences in audiovisual integration, as measured by McGurk phenomenon, among adult and adolescent patients with schizophrenia and age-matched healthy control groups
Pearl, Doron; Yodashkin-Porat, Dorit; Katz, Nachum; Valevski, Avi; Aizenberg, Dov; Sigler, Maayanit; Weizman, Abraham; Kikinzon, Leonid
分享
收藏
分享
收藏
分享
收藏
分享
收藏